Ro4-1539 (Furethylnorlevorphanol) is an opioid analgesic drug from the morphinan series that was developed by the pharmaceutical company Hoffmann–La Roche in the 1950s. It acts as a potent μ-opioid agonist and was found to be around 30-60x more potent than the related drug levorphanol in animal experiments.
This page contains content from the copyrighted Wikipedia article "Ro4-1539"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
